» Articles » PMID: 15296564

Symptomatic Diagnosis of Prostate Cancer in Primary Care: a Structured Review

Overview
Journal Br J Gen Pract
Specialty Public Health
Date 2004 Aug 7
PMID 15296564
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prostate cancer has the second highest cancer incidence and mortality in European men. Most prostate cancers are diagnosed after lower urinary tract symptoms (LUTS) are presented to primary care, but such symptoms more often have a benign cause. A general practitioner (GP) has to try and identify which of these patients have prostate cancer.

Aims: To review the presenting features of symptomatic prostate cancer.

Design Of Study: Structured review.

Method: We searched Medline from 1980 to 2003 for symptoms, signs, and investigations reported in prostate cancer. This list was then expanded by secondary searches of reference lists. We excluded studies on post-diagnostic topics, such as staging, treatment, and prognosis; studies on non-Western patients; and studies on investigations that are not available in primary care. A second cycle of exclusions removed studies whose results would not guide a GP in deciding whether a patient has prostate cancer.

Results: No studies from primary care compared prostate cancer patients directly with controls. Two secondary care studies had enough information to allow a comparison of symptoms in cases compared with controls. In these studies, symptoms were generally more prevalent in cases, but the differences were small. Screening and secondary care studies suggest that early prostate cancer is symptomless, and that locally advanced cancer has LUTS that are similar to those for benign prostatic hypertrophy.

Conclusion: There is a very weak evidence base for the primary care diagnosis of prostate cancer in men with lower urinary tract symptoms.

Citing Articles

Association of Prostate-Specific Antigen With Age, Digital Rectal Examination, and Lower Urinary Tract Symptoms in the Lebanese Population: A Cross-Sectional Study.

Tlaiss Y, Jreij M, Tlais M, Yammine Z, Najjar A, Naoufal R Cureus. 2024; 16(8):e66991.

PMID: 39280568 PMC: 11402275. DOI: 10.7759/cureus.66991.


Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.

Shi Y, Cao T, Xu J, Cui D, Wang X, Zhu Y Lasers Med Sci. 2023; 38(1):188.

PMID: 37596454 DOI: 10.1007/s10103-023-03848-5.


Clinical significance of prostate volume and testosterone reduction on lower urinary tract symptoms in patients with prostate cancer undergoing androgen deprivation therapy.

Bang W, Kim H, Oh C, Jo J, Cho J, Shim M Sci Rep. 2022; 12(1):18535.

PMID: 36323749 PMC: 9630373. DOI: 10.1038/s41598-022-21963-1.


Plasma Polyamine Biomarker Panels: Agmatine in Support of Prostate Cancer Diagnosis.

Coradduzza D, Solinas T, Azara E, Culeddu N, Cruciani S, Zinellu A Biomolecules. 2022; 12(4).

PMID: 35454104 PMC: 9024899. DOI: 10.3390/biom12040514.


Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.

Marima R, Hull R, Mbeje M, Molefi T, Mathabe K, Elbagory A Int J Mol Sci. 2022; 23(2).

PMID: 35054814 PMC: 8776204. DOI: 10.3390/ijms23020628.


References
1.
Mettlin C, Lee F, Drago J, Murphy G . The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer. 1991; 67(12):2949-58. DOI: 10.1002/1097-0142(19910615)67:12<2949::aid-cncr2820671202>3.0.co;2-x. View

2.
Kane R, Littrup P, Babaian R, Drago J, Lee F, Chesley A . Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project. Cancer. 1992; 69(5):1201-7. DOI: 10.1002/cncr.2820690522. View

3.
Sakr W, Haas G, Cassin B, Pontes J, Crissman J . The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 1993; 150(2 Pt 1):379-85. DOI: 10.1016/s0022-5347(17)35487-3. View

4.
Simons B, MORRISON A, Young R . The relation of surgery for prostatic hypertrophy to carcinoma of the prostate. Am J Epidemiol. 1993; 138(5):294-300. DOI: 10.1093/oxfordjournals.aje.a116858. View

5.
Viswanath S, Palmer M, Ojha H, Desmond A . Routine estimation of prostate specific antigen prior to clinic attendance in patients with symptoms of bladder outlet obstruction. Br J Urol. 1993; 72(2):187-9. DOI: 10.1111/j.1464-410x.1993.tb00685.x. View